These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1702360)
1. Identification of high mobility group protein I(Y) as potential progression marker for prostate cancer by differential hybridization analysis. Bussemakers MJ; van de Ven WJ; Debruyne FM; Schalken JA Cancer Res; 1991 Jan; 51(2):606-11. PubMed ID: 1702360 [TBL] [Abstract][Full Text] [Related]
2. Increased expression of high mobility group protein I(Y) in high grade prostatic cancer determined by in situ hybridization. Tamimi Y; van der Poel HG; Denyn MM; Umbas R; Karthaus HF; Debruyne FM; Schalken JA Cancer Res; 1993 Nov; 53(22):5512-6. PubMed ID: 8221692 [TBL] [Abstract][Full Text] [Related]
3. Down modulation of fibronectin messenger RNA in metastasizing rat prostatic cancer cells revealed by differential hybridization analysis. Schalken JA; Ebeling SB; Isaacs JT; Treiger B; Bussemakers MJ; de Jong ME; Van de Ven WJ Cancer Res; 1988 Apr; 48(8):2042-6. PubMed ID: 3349475 [TBL] [Abstract][Full Text] [Related]
5. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551 [TBL] [Abstract][Full Text] [Related]
6. Increased expression of retroviral sequences in progressionally advanced rat prostatic tumors. Bussemakers MJ; van Bokhoven A; van Groningen JJ; Debruyne FM; Schalken JA Biochem Biophys Res Commun; 1992 Jan; 182(1):318-24. PubMed ID: 1370615 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of protein kinase C isozyme messenger RNAs in dunning R-3327 rat prostatic tumors. Powell CT; Fair WR; Heston WD Cell Growth Differ; 1994 Feb; 5(2):143-9. PubMed ID: 8180127 [TBL] [Abstract][Full Text] [Related]
8. A novel human prostate-specific gene-1 (HPG-1): molecular cloning, sequencing, and its potential involvement in prostate carcinogenesis. Herness EA; Naz RK Cancer Res; 2003 Jan; 63(2):329-36. PubMed ID: 12543784 [TBL] [Abstract][Full Text] [Related]
9. Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF. Gretzer MB; Chan DW; van Rootselaar CL; Rosenzweig JM; Dalrymple S; Mangold LA; Partin AW; Veltri RW Prostate; 2004 Sep; 60(4):325-31. PubMed ID: 15264244 [TBL] [Abstract][Full Text] [Related]
10. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer. Xia W; Unger P; Miller L; Nelson J; Gelman IH Cancer Res; 2001 Jul; 61(14):5644-51. PubMed ID: 11454719 [TBL] [Abstract][Full Text] [Related]
11. Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer. Khanna N; Reddy VG; Tuteja N; Singh N Biochem Biophys Res Commun; 2000 Oct; 277(2):476-86. PubMed ID: 11032747 [TBL] [Abstract][Full Text] [Related]
12. AIbZIP, a novel bZIP gene located on chromosome 1q21.3 that is highly expressed in prostate tumors and of which the expression is up-regulated by androgens in LNCaP human prostate cancer cells. Qi H; Fillion C; Labrie Y; Grenier J; Fournier A; Berger L; El-Alfy M; Labrie C Cancer Res; 2002 Feb; 62(3):721-33. PubMed ID: 11830526 [TBL] [Abstract][Full Text] [Related]
13. Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. Tsavaler L; Shapero MH; Morkowski S; Laus R Cancer Res; 2001 May; 61(9):3760-9. PubMed ID: 11325849 [TBL] [Abstract][Full Text] [Related]
14. Identification of a human glioma-associated growth factor gene, granulin, using differential immuno-absorption. Liau LM; Lallone RL; Seitz RS; Buznikov A; Gregg JP; Kornblum HI; Nelson SF; Bronstein JM Cancer Res; 2000 Mar; 60(5):1353-60. PubMed ID: 10728698 [TBL] [Abstract][Full Text] [Related]
16. High expression of a new marker PCA-1 in human prostate carcinoma. Konishi N; Nakamura M; Ishida E; Shimada K; Mitsui E; Yoshikawa R; Yamamoto H; Tsujikawa K Clin Cancer Res; 2005 Jul; 11(14):5090-7. PubMed ID: 16033822 [TBL] [Abstract][Full Text] [Related]
17. Molecular cloning of five messenger RNAs differentially expressed in preneoplastic or neoplastic JB6 mouse epidermal cells: one is homologous to human tissue inhibitor of metalloproteinases-3. Sun Y; Hegamyer G; Colburn NH Cancer Res; 1994 Mar; 54(5):1139-44. PubMed ID: 8118794 [TBL] [Abstract][Full Text] [Related]
18. Alteration of gonadotropin-releasing hormone receptor expression with the progression of prostate cancer in the Dunning rat adenocarcinoma sublines. Tieva A; Bergh A; Damber JE Acta Oncol; 2005; 44(3):299-303. PubMed ID: 16076703 [TBL] [Abstract][Full Text] [Related]
19. Expression of bcl-2 and the progression of human and rodent prostatic cancers. Furuya Y; Krajewski S; Epstein JI; Reed JC; Isaacs JT Clin Cancer Res; 1996 Feb; 2(2):389-98. PubMed ID: 9816182 [TBL] [Abstract][Full Text] [Related]
20. Isolation of expressed sequences that include a gene for familial breast cancer (BRCA2) and other novel transcripts from a five megabase region on chromosome 13q12. Jacob AN; Kandpal G; Kandpal RP Oncogene; 1996 Jul; 13(1):213-21. PubMed ID: 8700550 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]